Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025)
Bicycle Therapeutics' (BCYC) quarterly Current Leases came in at $2.6 million in Q4 2025, down 52.12% YoY from $5.3 million in Q4 2024, and down 51.25% on a QoQ basis from $5.2 million in Q2 2025.
Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025) Analysis & Trends
Bicycle Therapeutics (BCYC) has 7 years of Current Leases data on file, last reported at $2.6 million in Q4 2025.
- Quarterly Current Leases fell 52.12% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (down 52.12% YoY) and the FY2025 annual result came in at $2.6 million, down 52.12% from the prior year.
- Current Leases slipped to $2.6 million in Q4 2025, from $5.2 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $5.5 million in Q1 2025 to a low of $708000.0 in Q1 2021.
- A 5-year average of $3.7 million and a median of $4.7 million in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases surged 323.16% — and 2025, when it slumped 52.12%.
- Tracing BCYC's Current Leases over 5 years: stood at $2.4 million in 2021, then soared by 31.14% to $3.1 million in 2022, then jumped by 56.03% to $4.9 million in 2023, then grew by 9.27% to $5.3 million in 2024, then tumbled by 52.12% to $2.6 million in 2025.
- The last three Current Leases figures came in at $2.6 million (Q4 2025), $5.2 million (Q2 2025), and $5.5 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Bicycle Therapeutics | 272.28 Mn | 272.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 205,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Dec 31, 2024 | 5.33 Mn |
| Sep 30, 2024 | 5.37 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | 4.88 Mn |
| Sep 30, 2023 | 4.66 Mn |
| Jun 30, 2023 | 4.68 Mn |
| Mar 31, 2023 | 4.66 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | 826,000.00 |
| Jun 30, 2021 | 773,000.00 |
| Mar 31, 2021 | 708,000.00 |
| Dec 31, 2020 | 844,000.00 |